Saturday, 5 September 2026European Markets

EASE2PAY NV Stock Bearish By 30% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of EASE2PAY NV (AEX-Index: EAS2P.AS) fell by a staggering 30.23% in 21 sessions from €0.86 to €0.60 at 17:09 EST on Tuesday, after two successive sessions in a row of losses. AEX-Index is sliding 0.11% to €766.80, after five consecutive sessions in a row of gains.

EASE2PAY NV's last close was €0.59, 77.89% below its 52-week high of €2.65.

About EASE2PAY NV

Ease2pay N.V. provides online payment services and platform in the Netherlands. It offers payment transaction platform, which offers users services to order and pay in one action and parking solutions. The company was formerly known as DOCDATA N.V. and changed its name to Ease2pay N.V. in February 2018. Ease2pay N.V. is headquartered in Waalwijk, the Netherlands. Ease2pay N.V. is a subsidiary of The Internet of Cars V.O.F.

Earnings Per Share

As for profitability, EASE2PAY NV has a trailing twelve months EPS of €-0.1.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -9.6%.

Volume

Today's last reported volume for EASE2PAY NV is 7960 which is 64.85% below its average volume of 16788.

Moving Average

EASE2PAY NV's value is way below its 50-day moving average of €1.11 and way under its 200-day moving average of €1.68.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1331%, now sitting on 1.86M for the twelve trailing months.

More news about EASE2PAY NV (EAS2P.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com